search
Back to results

BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart) (BESmart)

Primary Purpose

Obesity, Bariatric Surgery Candidate

Status
Active
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
smart visit app
Sponsored by
Wuerzburg University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring App, Empowerment, Obesity, bariatric surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

General inclusion criteria: Smartphone available (iOS or Android with sufficient version of the operating system). Age >/= 18 years Sufficient language skills to answer the questionnaires Additional group specific inclusion criteria: Group 1 (bariatric-metabolic surgery): • Bariatric-metabolic surgery (sleeve gastrectomy, Roux-Y gastric bypass, omega-loop bypass) at least 24 months ago. Group 2 (multimodal treatment): • Participation in a full or partial (if primary indication) multimodal approach. Group 3 (conservative therapy): BMI 28-34.9 kg/m2 No planned bariatric-metabolic surgery Desire for conservative weight reduction Exclusion Criteria: • current pregnancy

Sites / Locations

  • Ann-Cathrin D Koschker

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

group1

group 2

group 3

Arm Description

Bariatric-metabolic surgery (Gastric sleeve, Roux-Y gastric bypass, omega-loop bypass) at least 24 months ago, 25-45 patients in this group (total sum of patients in all three groups: 100).

Patients participating in a full or partial (if primary indication) multimodal approach prior to bariatric surgery, 25-45 patients in this group (total sum of patients in all three groups: 100).

Conservative therapy: patients with overweight/obesity grade 1 (BMI 28-34.9 kg/m2), 25-45 patients in this group (total sum of patients in all three groups: 100).

Outcomes

Primary Outcome Measures

satisfaction with and use of smart visit app designed for obesity them self-manage their condition. Analysis of all 3 groups cumulated. Coprimary endpoint
acceptance: questionnaire assessing the satisfaction with the app (scale 0-100, 0 meaning least possible satisfaction, 100 meaning best possible satisfaction) use: precentage of entered values in the app of the intended values (scale 0-100, 0 meaning no entered values, 100 meaning all intented values were entered)

Secondary Outcome Measures

satisfaction with and use of smart visit app designed for obesity them self-manage their condition. Analysis of all 3 groups cumulated. Coprimary endpoint.
acceptance: questionnaire assessing the satisfaction with the app (scale 0-100, 0 meaning least possible satisfaction, 100 meaning best possible satisfaction) use: precentage of entered values in the app of the intended values (scale 0-100, 0 meaning no entered values, 100 meaning all intented values were entered)
change in weight
change in weight in kilograms
change in quality of life by SF-36
measured by SF-36 (short form-36) questionnaire, z-transformed scale, 0 meaning worst possible quality of life, 100 meaning best possible quality of life
change in obesity related quality of life by BQL
measured by BQL (bariatric quality of life) questionnaire index, 0 meaning worst possible quality of life, 100 meaning best possible quality of life
change in quality of life by EQ-5D-5L
measured by EQ-5D-5L questionnaire (European Quality of Life 5 Dimensions 5 Level Version)
Depressive symptoms
measured by PHQ-9 questionnaire (Public Health Questionnaire-9), 0 meaning least possible depressive symptoms, 27 meaning worst possible depressive symptoms
Eating behavior
measured by EDE-Q8 (Eating Disorder Examination Questionnaire Short Version)
Number of contacts patient - center via app
Number of contacts between patients and center via app
daily step counts
change in daily step counts as measured with a pedometer
daily protein intake
change in daily protein intake (entered into the app) in grams
daily calory intake
change in daily calory intake (entered into the app) in kcal
walking distance in 6 minute walk test
change in walking distance in the 6 minute walk test in meters
body composition: body fat measured by bioelectrical impedance analysis
change in body fat (in %)
body composition: phase angle measured by by bioelectrical impedance analysis
change in phase angle (in °)
vitamin B 12 deficiency (only group 1)
vitamin B12 levels below the lower limit of normal
folic acid deficiency (only group 1)
folic acid levels below the lower limit of normal, ferritin, hemoglobin, prealbumin, 25-OH vitamin D, zinc (only group 1)
iron deficiency (only group 1)
ferritin below the lower limit of normal
protein malnutrition (only group 1)
prealbumin below the lower limit of normal
vitamin D deficiency (only group 1)
25-OH vitamin D below the lower limit of normal
zinc deficiency (only group 1)
zinc below the lower limit of normal

Full Information

First Posted
March 31, 2022
Last Updated
September 24, 2023
Sponsor
Wuerzburg University Hospital
Collaborators
aycan Medical Systems LTD, Innere Aumuehlstr. 5, 97076 Wuerzburg , Germany
search

1. Study Identification

Unique Protocol Identification Number
NCT06061406
Brief Title
BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart)
Acronym
BESmart
Official Title
BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 2, 2021 (Actual)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wuerzburg University Hospital
Collaborators
aycan Medical Systems LTD, Innere Aumuehlstr. 5, 97076 Wuerzburg , Germany

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Obesity affects an increasing proportion of the population and is associated with numerous comorbidities that cause increased morbidity and mortality. The most effective therapy for morbid obesity is metabolic bariatric surgery. Surgical numbers are increasing worldwide. Before surgery, patients must try to reduce weight conservatively in a multimodal therapy concept. In addition, numerous protocols must be collected and appointments must be organized. Postoperatively, patients are expected to receive lifelong follow-up care, which increasingly overwhelms bariatric centers. People with overweight and obesity ° I are often left largely alone with the treatment of their disease. There is a considerable gap in care here. For the care of patients with obesity and empowerment in dealing with their disease, the smart visit app from the company aycan, which is adapted to obesity patients, is to be investigated. This is designed as a pilot project with the primary endpoint of usage and satisfaction (after 3 months, key secondary endpoint after 12 months). A total of 100 patients from 3 groups (postoperative, preoperative, permanent conservative with only overweight/obesity °I) will use the app for 1 year for this purpose.
Detailed Description
The prevalence of obesity has been increasing dramatically for decades. The comorbidities are manifold, and the treatment of obesity is a long-term, usually lifelong task. Metabolic-bariatric surgery offers the best results. However, even after bariatric-metabolic surgery, there is a need for lifelong follow-up to ensure the success of therapy and to identify and treat possible complications, nutritional problems or deficiencies in a timely manner. The treating centers are increasingly overwhelmed by the follow-up care of the numerous patients. At the same time, the guidelines of the professional societies recommend involving the patient in the success of his or her therapy and enabling him or her to play an active role in shaping his or her treatment. An app tailored to the treatment of obese people, which helps both in the self-organization of the patients in complying with the therapy recommendations and in maintaining contact with the center on a permanent basis and making low-threshold contact when necessary, would be a valuable addition to the existing therapy options for patients and centers alike. Such an app would also have its value in the preoperative patient, especially since a lot of documentation work has to be done by the patient in this phase. Patients whose obesity is not pronounced enough for a surgical procedure often complete nutritional counseling and exercise at their own expense without receiving support from experts. Here, too, there would be a need to supplement the therapy options with an appropriately coordinated app. For the care of patients with obesity and empowerment in dealing with their disease, the smart visit app from the company aycan, which is adapted to obesity patients, is to be investigated. This is designed as a pilot project with the primary endpoint of usage and satisfaction (after 3 months, key secondary endpoint after 12 months). A total of 100 patients from 3 groups (postoperative, preoperative, permanent conservative with only overweight/obesity °I) will use the app for 1 year for this purpose.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Bariatric Surgery Candidate
Keywords
App, Empowerment, Obesity, bariatric surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
group1
Arm Type
Experimental
Arm Description
Bariatric-metabolic surgery (Gastric sleeve, Roux-Y gastric bypass, omega-loop bypass) at least 24 months ago, 25-45 patients in this group (total sum of patients in all three groups: 100).
Arm Title
group 2
Arm Type
Experimental
Arm Description
Patients participating in a full or partial (if primary indication) multimodal approach prior to bariatric surgery, 25-45 patients in this group (total sum of patients in all three groups: 100).
Arm Title
group 3
Arm Type
Experimental
Arm Description
Conservative therapy: patients with overweight/obesity grade 1 (BMI 28-34.9 kg/m2), 25-45 patients in this group (total sum of patients in all three groups: 100).
Intervention Type
Device
Intervention Name(s)
smart visit app
Intervention Description
Patients use an obesity-adapted version of aycan's Smartvisit app, which helps track specific behaviors (diet, exercise), query potential problems/complaints, and manage medical documents in a structured way. A study nurse experienced in the field of nutrition/obesity contacts the patient if necessary and establishes contact with the center physician.
Primary Outcome Measure Information:
Title
satisfaction with and use of smart visit app designed for obesity them self-manage their condition. Analysis of all 3 groups cumulated. Coprimary endpoint
Description
acceptance: questionnaire assessing the satisfaction with the app (scale 0-100, 0 meaning least possible satisfaction, 100 meaning best possible satisfaction) use: precentage of entered values in the app of the intended values (scale 0-100, 0 meaning no entered values, 100 meaning all intented values were entered)
Time Frame
at 3 months
Secondary Outcome Measure Information:
Title
satisfaction with and use of smart visit app designed for obesity them self-manage their condition. Analysis of all 3 groups cumulated. Coprimary endpoint.
Description
acceptance: questionnaire assessing the satisfaction with the app (scale 0-100, 0 meaning least possible satisfaction, 100 meaning best possible satisfaction) use: precentage of entered values in the app of the intended values (scale 0-100, 0 meaning no entered values, 100 meaning all intented values were entered)
Time Frame
at 12 months
Title
change in weight
Description
change in weight in kilograms
Time Frame
at 3 months and 12 months
Title
change in quality of life by SF-36
Description
measured by SF-36 (short form-36) questionnaire, z-transformed scale, 0 meaning worst possible quality of life, 100 meaning best possible quality of life
Time Frame
at 3 months and 12 months
Title
change in obesity related quality of life by BQL
Description
measured by BQL (bariatric quality of life) questionnaire index, 0 meaning worst possible quality of life, 100 meaning best possible quality of life
Time Frame
at 3 months and 12 months
Title
change in quality of life by EQ-5D-5L
Description
measured by EQ-5D-5L questionnaire (European Quality of Life 5 Dimensions 5 Level Version)
Time Frame
at 3 months and 12 months
Title
Depressive symptoms
Description
measured by PHQ-9 questionnaire (Public Health Questionnaire-9), 0 meaning least possible depressive symptoms, 27 meaning worst possible depressive symptoms
Time Frame
at 3 months and 12 months
Title
Eating behavior
Description
measured by EDE-Q8 (Eating Disorder Examination Questionnaire Short Version)
Time Frame
at 3 months and 12 months
Title
Number of contacts patient - center via app
Description
Number of contacts between patients and center via app
Time Frame
at 3 months and 12 months
Title
daily step counts
Description
change in daily step counts as measured with a pedometer
Time Frame
at 3 months and 12 months
Title
daily protein intake
Description
change in daily protein intake (entered into the app) in grams
Time Frame
at 3 months and 12 months
Title
daily calory intake
Description
change in daily calory intake (entered into the app) in kcal
Time Frame
at 3 months and 12 months
Title
walking distance in 6 minute walk test
Description
change in walking distance in the 6 minute walk test in meters
Time Frame
at 3 months and 12 months
Title
body composition: body fat measured by bioelectrical impedance analysis
Description
change in body fat (in %)
Time Frame
at 3 months and 12 months
Title
body composition: phase angle measured by by bioelectrical impedance analysis
Description
change in phase angle (in °)
Time Frame
at 3 months and 12 months
Title
vitamin B 12 deficiency (only group 1)
Description
vitamin B12 levels below the lower limit of normal
Time Frame
at 3 months and 12 months
Title
folic acid deficiency (only group 1)
Description
folic acid levels below the lower limit of normal, ferritin, hemoglobin, prealbumin, 25-OH vitamin D, zinc (only group 1)
Time Frame
at 3 months and 12 months
Title
iron deficiency (only group 1)
Description
ferritin below the lower limit of normal
Time Frame
at 3 months and 12 months
Title
protein malnutrition (only group 1)
Description
prealbumin below the lower limit of normal
Time Frame
at 3 months and 12 months
Title
vitamin D deficiency (only group 1)
Description
25-OH vitamin D below the lower limit of normal
Time Frame
at 3 months and 12 months
Title
zinc deficiency (only group 1)
Description
zinc below the lower limit of normal
Time Frame
at 3 months and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
General inclusion criteria: Smartphone available (iOS or Android with sufficient version of the operating system). Age >/= 18 years Sufficient language skills to answer the questionnaires Additional group specific inclusion criteria: Group 1 (bariatric-metabolic surgery): • Bariatric-metabolic surgery (sleeve gastrectomy, Roux-Y gastric bypass, omega-loop bypass) at least 24 months ago. Group 2 (multimodal treatment): • Participation in a full or partial (if primary indication) multimodal approach. Group 3 (conservative therapy): BMI 28-34.9 kg/m2 No planned bariatric-metabolic surgery Desire for conservative weight reduction Exclusion Criteria: • current pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ann-Cathrin D Koschker
Organizational Affiliation
University Hospital Wuerzburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ann-Cathrin D Koschker
City
Wuerzburg
ZIP/Postal Code
97080
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

BE Smart - Bariatric Patient - Empowerment in the Preparation and Follow-up of Bariatric Surgery Using the Smartvisit App (BESmart)

We'll reach out to this number within 24 hrs